| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |